The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model

Frank I. Scott, Ravy K. Vajravelu, Meenakshi Bewtra, Ronac Mamtani, Dale Lee, David S. Goldberg, James D. Lewis

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model'. Together they form a unique fingerprint.

Medicine & Life Sciences